Question 266 · LEK · Cardiovascular risk and prevention of cardiovascular diseases
A 54-year-old woman treated with atorvastatin (40 mg daily) for hyperlipidemia for several years came for a control examination. She takes ramipril 10 mg because of arterial hypertension. She is not diabetic, her history is positive for TIA (transient ischemic attack). The examination shows: BMI 27.8 kg/m², RR 138/76 mmHg. Lab tests: total cholesterol 6.62 mmol/L (255 mg%), LDL-cholesterol 4.34 mmol/L (166 mg%), HDL-cholesterol 0.9 mmol/L (35 mg%), triglycerides 1.8 mmol/L (160 mg%), ALT in the normal range. Indicate the optimal management of her lipid disorders:
- A. addition of fibrates.
- B. addition of ezetimibe.
- C. addition of ion-exchange resins.
- D. addition of nicotinic acid.
- E. continuation of the pharmacological treatment, dietary counseling, body mass reduction.
Hint
Define her cardiovascular risk category after TIA, compare LDL-C with the target and pick the logical add-on to a statin.
The answer, the explanation and a note on every option are available once you log in. The account is free: topic tests, a mock exam, mistake review and statistics.
More questions on Internal medicine
- Which of the following is not characteristic of chronic obstructive pulmonary disease (COPD)?
- Red rash occurring after an exposure to sunlight and complete heart block in children of mothers suffering from systemic lupus erythematosus are…
- An increase in the mean corpuscular volume (MCV) may be caused by:
- Which of the following is not characteristic of chronic renal failure:
- A 34-year-old patient complains of nausea and pressure-like sensation behind the sternum, especially after solid meals. The symptoms occur…
- Indicate the medication which should not be used in the first-line treatment of hypertension: